Cross-reactivity of SARS-CoV structural protein antibodies against SARS-CoV-2
T. A. Bates, J. B. Weinstein, S. E. Farley, H. C. Leier, W. B. Messer, F. G. Tafesse
This study evaluates cross-reactivity of SARS-CoV structural protein antibodies against SARS-CoV-2 and finds a high proportion of tested antibodies show cross-reactivity, suggesting potential utility in research and therapeutic development.
bioRxiv · Jul 30, 2020Immunology